/주식/LYRA
LYRA

LYRA

USD

Lyra Therapeutics Inc. Common Stock

$12.830-0.500 (-3.751%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$13.330

고가

$13.502

저가

$11.670

거래량

0.20M

기업 기본 정보

시가총액

17.0M

산업

생명공학

국가

United States

거래 통계

평균 거래량

0.65M

거래소

NCM

통화

USD

52주 범위

저가 $3.81현재가 $12.830고가 $37.5

관련 뉴스

Analyst Upgrades

HC Wainwright & Co. Maintains Neutral on Lyra Therapeutics, Raises Price Target to $16

HC Wainwright & Co. analyst Matthew Caufield maintains Lyra Therapeutics with a Neutral and raises the price target from $2 to $16.

더 보기
HC Wainwright & Co. Maintains Neutral on Lyra Therapeutics, Raises Price Target to $16
GlobeNewswire

Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)

ENLIGHTEN 2 trial met primary endpoint with LYR-210 demonstrating statistically significant improvement in the composite of the three cardinal symptoms (3CS) of CRS at 24 weeks (p=0.0078)ENLIGHTEN 2 trial also showed

더 보기
Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)